| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | JUNO THERAPEUTICS INCORPORATED | 1,749,999 | 96,955,000 | 22.32% | ||
| 2 | Anacor Pharmaceuticals Inc | 1,178,474 | 68,175,000 | 15.70% | ||
| 3 | AVALANCHE BIOTECHNOLOGIES IN | 1,382,735 | 56,029,000 | 12.90% | ||
| 4 | DBV Technologies | 693,810 | 29,572,000 | 6.81% | ||
| 5 | GW PHARMACEUTICALS PLC | 311,853 | 28,419,000 | 6.54% | ||
| 6 | COHERUS BIOSCIENCES INC COM | 870,269 | 26,018,000 | 5.99% | ||
| 7 | ZAFGEN INC COM | 541,480 | 21,448,000 | 4.94% | ||
| 8 | DYAX CORP COM CVR | 1,000,659 | 16,766,000 | 3.86% | ||
| 9 | HERON THERAPEUTICS INC | 1,095,734 | 15,943,000 | 3.67% | ||
| 10 | BIOCRYST PHARMACEUTICALS | 1,744,356 | 15,752,000 | 3.63% | ||
| 11 | Ascendis Pharma | 811,152 | 12,911,000 | 2.97% | ||
| 12 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 500,000 | 8,990,000 | 2.07% | ||
| 13 | ALCOBRA LTD | 1,500,000 | 8,446,000 | 1.94% | ||
| 14 | STEMLINE THERAPEUTICS INC | 451,400 | 6,532,000 | 1.50% | ||
| 15 | Cynapsus Therapeutics Inc | 5,878,855 | 5,121,000 | 1.18% | ||
| 16 | THERAPEUTICSMD INC | 846,500 | 5,121,000 | 1.18% | ||
| 17 | LIPOCINE INC NEW | 669,921 | 4,622,000 | 1.06% | ||
| 18 | ZS PHARMA INC | 100,000 | 4,208,000 | 0.97% | ||
| 19 | OCERA THERAPEUTICS INC | 703,730 | 3,315,000 | 0.76% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-006018, filed 2015.05.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
